Research Articles | Page 9 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
A Case Series of Post-Transplantation Cyclophosphamide in Unrelated Donor Hematopoietic Cell Transplantation for Aplastic Anemia Jun 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation Aplastic Anemia
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia Dec 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation Aplastic Anemia
The case for upfront HLA-matched unrelated donor HCT as a curative option for adult acquired severe aplastic anemia: Upfront MUD HCT for adult severe aplastic anemia May 2019 Biology of Blood and Marrow Transplantation: Journal of the American Society of Blood and Marrow Transplantation Aplastic Anemia
Eltrombopag for refractory severe aplastic anemia: dosing, duration, long term outcomes and clonal evolution Apr 2019 Blood Aplastic Anemia
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings Apr 2023 Blood Myelodysplastic Syndromes (MDS)
Diagnosis and classification of myelodysplastic syndromes Dec 2023 Blood Myelodysplastic Syndromes (MDS)
SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM) Apr 2020 Blood Myelodysplastic Syndromes (MDS)
The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes Dec 2023 Blood Myelodysplastic Syndromes (MDS)
Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes Dec 2024 Blood Myelodysplastic Syndromes (MDS)
T cell dysfunctions in myelodysplastic syndromes Jan 2023 Blood Myelodysplastic Syndromes (MDS)